Abstract:OBJECTIVE:To study clinicopathologic features, diagnosis, treatment and prognosis of von Hippel-Lindau (VHL) syndrome-related and sporadic hemangioblastomas of the central nervous system (CNS-HB).METHODS:Histopathological, ultrastructural, immunohistochemical (EnVision method) and clinical features of 21 VHL syndrome and 63 sporadic CNS-HB cases were studied with correlation of the available follow-up information.RESULTS:Twenty-one VHL patients accompanied with a total of 87 CNS-HBs, including one patient of developing 12 HBs within 13 years. There were 10 patients presenting other lesions related to VHL, including 6 retinal HBs, 4 pancreatic tumors (endocrine tumor and microcystic cystadenoma), 1 clear renal cell carcinoma, 4 renal cysts and 1 endolymphatic sac tumor. One patient developed 5 different tumors related to VHL within a period of 4 years. In the 63 cases of sporadic CNS-HB (34 male and 29 female), the mean age was 43.0 years. Among the 18 VHL syndrome patients with available follow-up information, 14 were still alive and within them, 4 became disabled and 11 had developed new lesions. The other 4 patients died. Among the 42 patients of sporadic HB with follow-up information, 39 were alive including 3 disabled cases, and the other 3 died. Histologically, the tumors showed large and vacuolated stromal cells. Some tumors showed atypical nuclei. Involvement of the brain tissue was seen in 32 cases, among which, 21 patients with available follow-up information were learnt to be alive. Tumor cells of HB stained positive for vimentin, EGFR, Inhibin alpha and D2-40, but negative for CD34 and CD68. In 3 cases of HB, some stromal cells were positive for GFAP. All cases showed a low expression for Ki-67, except 2 cases with 2% and 1 case with 5% Ki-67 indices.CONCLUSIONS:VHL syndrome is a multisystem disorder with a poor prognosis and a high rate of missed diagnosis. The syndrome is characterized by development of various benign and malignant tumors. The most common tumor is CNS-HB, which occurs predominantly in the cerebellum. Patients with VHL syndrome tend to present at a younger age than patients with sporadic CNS-HBs, and VHL related HB occurs more predominantly in the brain stem and spinal cord. Prognosis of CNS-HB patients is not correlated with the nuclear atypicality, expression for Ki-67 and involvement of the brain tissue. Because new lesions may develop during the patient's lifetime. So that, regular clinical inspection is recommended in order to check up the development of any new lesions.

Central Nervous System Hemangioblastomas in the Elderly (over 65 Years): Clinical Characteristics and Outcome Analysis

Central Nervous System Hemangioblastomas: an Age-Stratified Analysis

Understanding Adult Central Nervous System Hemangioblastomas: A Systematic Review

Clinicopathologic Study of Von Hippel-Lindau Syndrome-Related and Sporadic Hemangioblastomas of Central Nervous System

Biological and Clinical Impact of Central Nervous System Hemangioblastomas in Chinese Patients with Von Hippel-Lindau Disease: Implications for Treatment

Hemangioblastomas of the Central Nervous System in Von Hippel-Lidau Syndrome and Sporadic Disease

Neurosurgical Management of Brainstem Hemangioblastomas: A Single-Institution Experience with 116 Patients

Clinical data analysis and long time following up in 312 cases of central nervous system hemangioblatomas

Assessment of Care Pattern and Outcome in Hemangioblastoma.

Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau Disease

Comparative analysis of stereotactic radiosurgery outcomes for supratentorial hemangioblastomas in von hippel-lindau disease and sporadic cases: A multi-center international study

Incidence, Prognostic Factors and Survival for Hemangioblastoma of the Central Nervous System: Analysis Based on the Surveillance, Epidemiology, and End Results Database

Epidemiology and Survival Analysis of Patients with Brainstem Cavernous Hemangioma: A Population-Based Study Using the SEER Database

RARE-15. PROGNOSTIC FACTORS, TREATMENT AND OUTCOME IN PATIENTS WITH INTRACRANIAL HEMANGIOBLASTOMA: A STUDY OF 3449 PATIENTS FROM THE NATIONAL CANCER DATA BASE

Clinical characteristics and surgical strategy of sporadic cerebellar hemangioblastomas

Stereotactic radiosurgery for central nervous system hemangioblastoma in von Hippel-Lindau disease: A systematic review and meta-analysis.

Germline mutation and clinical prognostic analysis of VHL gene in familial central nervous system hemangioblastoma

Clinicopathological characteristics, prognostic factors, and outcomes of elderly patients with lymphoma-associated hemophagocytic lymphohistiocytosis: A multicenter analysis

Stereotactic biopsy in elderly patients: risk assessment and impact on treatment decision

1077 Operative Management and Outcomes in Spinal Hemangioblastoma: A Multi-institutional Case Series of 59 Patients

Central Nervous System Hemangioblastoma in a Pediatric Patient Associated With Von Hippel-Lindau Disease: A Case Report and Literature Review